WCCO EYE4 LOGO WCCO Radio wcco-eye-white01, ww color white

Medtronic

Medtronic, building, generic

Del. Judge Rules In Pacemaker Patent Dispute

A federal judge in Delaware has ruled that certain heart pacemakers sold by Medtronic Inc. do not infringe patents claimed by rival medical device manufacturer Boston Scientific Corp.

03/31/2011

Medtronic, building, generic

Medtronic To Cut Up To 2,000 Jobs

Medtronic, the world’s largest medical device maker, said Tuesday it will lay off up to 2,000 workers as part of a restructuring effort to make up for anemic sales of its implants.

02/22/2011

(credit: CBS)

Medtronic’s New Technology Combats ‘Silent Killer’

Millions of people walk around with a potential time bomb inside and most do not know it. Medtronic now has a new device on the market to fight the so-called Silent Killer, Abdominal Aortic Aneurysm or AAA.

02/16/2011

(credit: CBS)

New Therapy For Heart Rhythm Problem

As Valentine’s Day approaches it may be good to have your heart all aflutter. But, for up to three million Americans, it is a daily occurrence and that is not a good thing.

02/09/2011

Medtronic, building, generic

Medtronic Gets OK For Scan-Friendly Pacemaker

Twin Cities-based Medtronic has received government approval for the first heart pacemaker designed to be safely used with MRI scanners.

02/08/2011

Medtronic, building, generic

Medtronic CEO Retiring In April

Medtronic said Monday that Chairman and CEO William A. Hawkins will step down in April after three years leading the world’s largest medical device manufacturer.

12/20/2010

Medtronic, building, generic

Medtronic 2Q Profit Falls 35 Percent On Costs

Medtronic’s fiscal second-quarter net income fell 35 percent as legal and other costs outpaced weak gains in medical device sales, but adjusted results met Wall Street expectations.

11/23/2010

Medtronic, building, generic

Studies: Drug, Device Help Treat Heart Failure

Millions of people with mild or moderate heart failure got good news Sunday, with studies showing a Pfizer drug and a device from Medtronic can boost survival and cut trips to the hospital by patients having trouble breathing.

11/14/2010

Medtronic To Settle Sprint Fidelis Suits For $268M

Medtronic said Thursday it has agreed to pay $268 million to settle U.S. lawsuits and claims related to its Sprint Fidelis family of defibrillation leads which it recalled three years ago.

10/14/2010

previous